Patents by Inventor Annat Raiter

Annat Raiter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF DISEASES WITH MULTIMERIC PEPTIDES
    Publication number: 20220120732
    Abstract: Methods of treating diseases selected from the group consisting of an autoimmune disease, a neurodegenerative disease, triple negative breast cancer, head and neck cancer and an infectious disease are disclosed. The method comprises administering agents that bind to CD45.
    Type: Application
    Filed: February 21, 2020
    Publication date: April 21, 2022
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventor: Annat RAITER
  • Compositions and methods for inducing angiogenesis
    Patent number: 8741843
    Abstract: An isolated peptide comprising an amino acid sequence HWRR as set forth by SEQ ID NO:5, the peptide consists of 4 or 5 amino acids, is provided. Also provided are methods of treating angiogenesis-related pathologies using the peptide of the invention or pharmaceutical compositions comprising same.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: June 3, 2014
    Inventors: Britta Hardy, Alexander Battler, Annat Raiter, Chana Weiss
  • COMPOSITIONS AND METHODS FOR INDUCING ANGIOGENESIS
    Publication number: 20120219498
    Abstract: An isolated peptide comprising an amino acid sequence HWRR as set forth by SEQ ID NO:5, the peptide consists of 4 or 5 amino acids, is provided. Also provided are methods of treating angiogenesis-related pathologies using the peptide of the invention or pharmaceutical compositions comprising same.
    Type: Application
    Filed: May 10, 2012
    Publication date: August 30, 2012
    Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: BRITTA HARDY, ALEXANDER RATTLER, ANNAT RAITER, CHANA WEISS
  • Compositions and methods for inducing angiogenesis
    Patent number: 8227413
    Abstract: An isolated peptide comprising an amino acid sequence HWRR as set forth by SEQ ID NO:5, the peptide consists of 4 or 5 amino acids, is provided. Also provided are methods of treating angiogenesis-related pathologies using the peptide of the invention or pharmaceutical compositions comprising same.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: July 24, 2012
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Britta Hardy, Alexander Battler, Annat Raiter, Chana Weiss
  • Compositions and Methods for Inducing Angiogenesis
    Publication number: 20100322856
    Abstract: An isolated peptide comprising an amino acid sequence HWRR as set forth by SEQ ID NO:5, the peptide consists of 4 or 5 amino acids, is provided. Also provided are methods of treating angiogenesis-related pathologies using the peptide of the invention or pharmaceutical compositions comprising same.
    Type: Application
    Filed: October 18, 2007
    Publication date: December 23, 2010
    Applicant: Ramot At Tel Aviv University Ltd.
    Inventors: Britta Hardy, Alexander Battler, Annat Raiter, Chana Weiss
  • Peptide useful in immunomodulation
    Patent number: 7745397
    Abstract: The present invention provides peptides and polynucleotides, and their use for immunomodulation, immunotherapy and vaccine particularly for anti-cancer therapy, and for diagnosis purposes. The immunomodulatory effect includes induction of proliferation and activation of peripheral blood lymphocytes and induction of an anti-tumor effect upon administration of peptides of the invention to subjects suffering from cancer.
    Type: Grant
    Filed: December 14, 2007
    Date of Patent: June 29, 2010
    Assignees: CureTech Ltd., Mor-Research Applications Ltd.
    Inventors: Britta Hardy, Annat Raiter, Leah Klapper
  • Angiogenic peptides and uses thereof
    Publication number: 20090163405
    Abstract: A peptide comprising an amino acid sequence as set forth in SEQ ID NO: 2, 4, 6, 8, 10 or 12 is provided. The peptide being at least 6 and no more than 50 amino acid residues in length. Also provided are therapeutic applications using such peptides.
    Type: Application
    Filed: November 28, 2008
    Publication date: June 25, 2009
    Applicant: Ramot At Tel Aviv University Ltd.
    Inventors: Britta Hardy, Alexander Battler, Annat Raiter, Ran Kornowski, Chana Weiss
  • USE OF BAT MONOCLONAL ANTIBODY FOR IMMUNOTHERAPY
    Publication number: 20090123413
    Abstract: The present invention relates to immunotherapy and more specifically concerns the use of immunostimulatory BAT monoclonal antibodies for treatment of a variety of immunodeficiency related diseases and disorders and malfunction or incompetence of the immune system.
    Type: Application
    Filed: August 23, 2005
    Publication date: May 14, 2009
    Inventors: Britta Hardy, Annat Raiter, Michael Schickler
  • Angiogenic peptides and uses thereof
    Patent number: 7473682
    Abstract: A peptide comprising an amino acid sequence as set forth in SEQ ID NO: 2, 4, 6, 8, 10 or 12 is provided. The peptide being at least 6 and no more than 50 amino acid residues in length. Also provided are therapeutic applications using such peptides.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: January 6, 2009
    Assignee: Ramot at Tel Aviv University Ltd.
    Inventors: Britta Hardy, Alexander Battler, Annat Raiter, Ran Kornowski, Chana Weiss
  • PEPTIDE USEFUL IN IMMUNOMODULATION
    Publication number: 20080175855
    Abstract: The present invention provides peptides and polynucleotides, and their use for immunomodulation, immunotherapy and vaccine particularly for anti-cancer therapy, and for diagnosis purposes. The immunomodulatory effect includes induction of proliferation and activation of peripheral blood lymphocytes and induction of an anti-tumor effect upon administration of peptides of the invention to subjects suffering from cancer.
    Type: Application
    Filed: December 14, 2007
    Publication date: July 24, 2008
    Applicants: Curetech Ltd., Mor-Research Applications Ltd.
    Inventors: Britta Hardy, Annat Raiter, Leah Klapper
  • Peptide useful in immunomodulation
    Patent number: 7329639
    Abstract: The present invention provides peptides and polynucleotides, and their use for immunomodulation, immunotherapy and vaccine particularly for anti-cancer therapy, and for diagnosis purposes. The immunomodulatory effect includes induction of proliferation and activation of peripheral blood lymphocytes and induction of an anti-tumor effect upon administration of peptides of the invention to subjects suffering from cancer.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: February 12, 2008
    Assignees: CureTech Ltd., Mor-Research Applications Ltd.
    Inventors: Britta Hardy, Annat Raiter, Leah Klapper
  • Angiogenic peptides and uses thereof
    Publication number: 20070082849
    Abstract: A peptide comprising an amino acid sequence as set forth in SEQ ID NO: 2, 4, 6, 8, 10 or 12 is provided. The peptide being at least 6 and no more than 50 amino acid residues in length. Also provided are therapeutic applications using such peptides.
    Type: Application
    Filed: October 28, 2004
    Publication date: April 12, 2007
    Applicant: Ramot At Aviv University Ltd.
    Inventors: Britta Hardy, Alexander Battler, Annat Raiter, Ran Kornowski, Chana Weiss
  • Peptide useful in immunomodulation
    Patent number: 7122372
    Abstract: The present invention provides peptides and polynucleotides, and their use for immunomodulation, immunotherapy and vaccine particularly for anti-cancer therapy, and for diagnosis purposes. The immunomodulatory effect includes induction of proliferation and activation of peripheral blood lymphocytes and induction of an anti-tumor effect upon administration of peptides of the invention to subjects suffering from cancer.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: October 17, 2006
    Assignees: CureTech Ltd., Mor-Research Applications Ltd.
    Inventors: Britta Hardy, Annat Raiter, Leah Klapper
  • Peptide useful in immunomodulation
    Publication number: 20060210573
    Abstract: The present invention provides peptides and polynucleotides, and their use for immunomodulation, immunotherapy and vaccine particularly for anti-cancer therapy, and for diagnosis purposes. The immunomodulatory effect includes induction of proliferation and activation of peripheral blood lymphocytes and induction of an anti-tumor effect upon administration of peptides of the invention to subjects suffering from cancer.
    Type: Application
    Filed: April 27, 2006
    Publication date: September 21, 2006
    Applicants: Curetech Ltd.,, Mor-Research Applications Ltd.,
    Inventors: Britta Hardy, Annat Raiter, Leah Klapper
  • Peptide useful in immunomodulation
    Publication number: 20050003397
    Abstract: The present invention provides peptides and polynucleotides, and their use for immunomodulation, immunotherapy and vaccine particularly for anti-cancer therapy, and for diagnosis purposes. The immunomodulatory effect includes induction of proliferation and activation of peripheral blood lymphocytes and induction of an anti-tumor effect upon administration of peptides of the invention to subjects suffering from cancer.
    Type: Application
    Filed: April 9, 2004
    Publication date: January 6, 2005
    Inventors: Britta Hardy, Annat Raiter, Leah Klapper